Tokio Marine Asset Management Co. Ltd. Has $341,000 Stake in Teleflex Incorporated (NYSE:TFX)

Tokio Marine Asset Management Co. Ltd. boosted its stake in Teleflex Incorporated (NYSE:TFX) by 22.3% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 1,366 shares of the medical technology company’s stock after buying an additional 249 shares during the quarter. Tokio Marine Asset Management Co. Ltd.’s holdings in Teleflex were worth $341,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also bought and sold shares of TFX. Exchange Traded Concepts LLC raised its position in Teleflex by 157.5% in the 3rd quarter. Exchange Traded Concepts LLC now owns 273 shares of the medical technology company’s stock valued at $54,000 after buying an additional 167 shares during the last quarter. Czech National Bank raised its position in Teleflex by 47.7% in the 3rd quarter. Czech National Bank now owns 8,213 shares of the medical technology company’s stock valued at $1,613,000 after buying an additional 2,653 shares during the last quarter. Asset Management One Co. Ltd. raised its position in Teleflex by 0.3% in the 3rd quarter. Asset Management One Co. Ltd. now owns 19,230 shares of the medical technology company’s stock valued at $3,777,000 after buying an additional 60 shares during the last quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund raised its position in Teleflex by 1.7% in the 3rd quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund now owns 12,208 shares of the medical technology company’s stock valued at $2,398,000 after buying an additional 200 shares during the last quarter. Finally, Xponance Inc. raised its position in Teleflex by 5.1% in the 3rd quarter. Xponance Inc. now owns 6,780 shares of the medical technology company’s stock valued at $1,332,000 after buying an additional 328 shares during the last quarter. 95.62% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other Teleflex news, VP Cameron P. Hicks sold 7,401 shares of the firm’s stock in a transaction dated Tuesday, March 5th. The stock was sold at an average price of $225.00, for a total value of $1,665,225.00. Following the completion of the transaction, the vice president now owns 10,050 shares in the company, valued at approximately $2,261,250. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. 1.43% of the stock is owned by corporate insiders.

Teleflex Price Performance

TFX stock opened at $206.71 on Monday. The company has a debt-to-equity ratio of 0.39, a quick ratio of 1.29 and a current ratio of 2.32. The company has a market capitalization of $9.74 billion, a price-to-earnings ratio of 27.45, a PEG ratio of 1.98 and a beta of 1.11. Teleflex Incorporated has a fifty-two week low of $177.63 and a fifty-two week high of $276.43. The stock has a fifty day moving average of $221.23 and a 200-day moving average of $226.03.

Teleflex (NYSE:TFX) last posted its quarterly earnings results on Thursday, February 22nd. The medical technology company reported $3.38 earnings per share for the quarter, topping the consensus estimate of $3.26 by $0.12. The company had revenue of $773.90 million during the quarter, compared to the consensus estimate of $769.01 million. Teleflex had a return on equity of 14.98% and a net margin of 11.98%. The firm’s quarterly revenue was up 2.1% compared to the same quarter last year. During the same quarter in the prior year, the company earned $3.52 EPS. As a group, equities research analysts predict that Teleflex Incorporated will post 13.73 earnings per share for the current year.

Teleflex Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, March 15th. Shareholders of record on Friday, March 1st were paid a $0.34 dividend. The ex-dividend date of this dividend was Thursday, February 29th. This represents a $1.36 annualized dividend and a yield of 0.66%. Teleflex’s dividend payout ratio is currently 18.06%.

Analyst Upgrades and Downgrades

TFX has been the subject of a number of analyst reports. Truist Financial lowered their price target on Teleflex from $270.00 to $265.00 and set a “hold” rating for the company in a research report on Friday, February 23rd. JMP Securities restated a “market outperform” rating and issued a $285.00 price objective on shares of Teleflex in a research note on Friday, February 23rd. Royal Bank of Canada reduced their price objective on Teleflex from $272.00 to $265.00 and set an “outperform” rating for the company in a research note on Friday, February 23rd. Finally, StockNews.com downgraded Teleflex from a “buy” rating to a “hold” rating in a research note on Friday, February 23rd. Four equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $267.50.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.